FIT screening

The FIT-based screening test is easy and therefore manages to attract high participation rates – the main driver behind the success of any national or regional screening programme. Generally, national or regional administrations assume responsibility for managing the logistics, financials and efficiency of the programme in close cooperation with their selected laboratory partners.

For further information, you can check our FIT for screening microsite. 
www.fitscreening.eu/

 

 

OSNA – THE NEW GENERATION OF SENTINEL LYMPH NODE ANALYSIS FOR BREAST CANCER

The sentinel lymph node biopsy (SLNB) has become established as the gold standard for clinically node-negative patients with primary mammary carcinomas. To exploit the benefits of this procedure, the sentinel lymph nodes are often analysed intra-operatively. The investigation is often made using frozen section or imprint cytology with subsequent HE stain (haematoxylin-eosin). These histopathological methods, however, have limited sensitivity, as only a small section of the lymph node tissue can be investigated during surgery. In contrast, the OSNA® system allows the intraoperative analysis of the entire lymph node, thereby allowing a more accurate assessment of the extent of the metastatic spread. An earlier definitive decision on the necessary therapeutic measures can then be made during the surgical procedure.

•    The entire lymph node can be analysed
•    Intraoperative decision, immediate and reliable
•    Clear indication of the axillary status
•    Second operations can be avoided
•    Immediate reconstructions possible
•    Prompt initiation of further therapeutic measures
•    Shorter waiting time and less stress for the patient

Clinical evidence

Oncology Overview

Go back to the overview of Oncology

Click Here
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
SUSPECTED HUS IN ROUTINE ANALYSIS
See the Podcast